NEUROTECH PHARMACEUTICALS
Live / Allowed — Notice of allowance issued (as of 27 May 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Mar 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98448996
- Mark type
- Design + words
- Filed
- 14 Mar 2024
- Published for opposition
- 01 Apr 2025
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of ophthalmic diseases and disorders; intravitreal implants, namely, implantable drug delivery devices sold filled with a pharmaceutical for the treatment of eye and vision conditions
- Class 010 — Medical apparatus: Medical devices for the prevention and treatment of ophthalmic diseases and disorders; medical device, namely, intraocular implant
Owner
- Neurotech Pharmaceuticals, Inc., Cumberland, RI, US
- Neurotech Pharmaceuticals, Inc., Cumberland, RI, US
Prosecution history
- 07 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 05 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 05 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 05 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 12 Dec 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 12 Dec 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Sept 2024 — NON-FINAL ACTION E-MAILED
- 26 Sept 2024 — NON-FINAL ACTION WRITTEN